EUVIMEDEUVIMED entdecken
Open Access

Prevalence of SARS‐CoV‐2 infection among US blood donors by industry, May–December 2021

Dallas S Shi iD, Emily McDonald, Melisa Shah, Matthew R Groenewold iD, James M Haynes, Bryan R Spencer, Susan L Stramer, Leora R Feldstein, Sharon Saydah, Jefferson Jones, Sophia K Chiu, Jessica L Rinsky

American Journal of Industrial Medicine · 2024

DOI: 10.1002/ajim.23552 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Industrial Medicine, 2024. Verfasst von Dallas S Shi und 11 weiteren Autor:innen. Beteiligte Einrichtung: Division of Field Studies and Engineering, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, Cincinn…. Hauptthemen laut MEDLINE: Blood Donors, COVID-19. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Intramural CDC HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Work is a social determinant of health that is often overlooked. There are major work‐related differences in the risk of severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) infection and death, but there have been few analyses of infection rates across industry groups. To date, only one national assessment of SARS‐CoV‐2 infection prevalence by industry based on self‐report has been completed. No study has looked at seroprevalence of COVID‐19 by industry.

Methods

During May–December 2021, blood donors with SARS‐CoV‐2 antinucleocapsid testing were sent an electronic survey about their work. Free‐text industry responses were classified using the North American Industry Classification System. We estimated seroprevalence and 95% confidence intervals (CIs) of SARS‐CoV‐2 infection by industry.

Results

Of 57,726 donors, 7040 (12%, 95% CI: 11.9%−12.5%) had prior SARS‐CoV‐2 infection. Seroprevalence was highest among Accommodation & Food Services (19.3%, 95% CI: 17.1%−21.6%), Mining, Quarrying, and Oil and Gas Extraction (19.2%, 95% CI: 12.8%−27.8%), Healthcare & Social Assistance (15.6%, 95% CI: 14.9%−16.4%), and Construction (14.7%, 95% CI: 13.1%−16.3%). Seroprevalence was lowest among Management of Companies & Enterprises (6.5%, 95% CI: 3.5%−11.5%), Professional Scientific & Technical Services (8.4%, 95% CI: 7.7%−9.0%), and Information (9.9%, 95% CI: 8.5%−11.5%).

Conclusions

While workers in all industries had serologic evidence of SARS‐CoV‐2 infection, certain sectors were disproportionately impacted. Disease surveillance systems should routinely collect work characteristics so public health and industry leaders can address health disparities using sector‐specific policies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Blood DonorsCOVID-19HumansSARS-CoV-2PrevalenceSeroepidemiologic StudiesSelf ReportAntibodies, Viral

Stichwörter der Autor:innen

COVID-19SARS-CoV-2blood donorsindustryseroprevalencework

Substanzen

Antibodies, Viral

Autor:innen und Institutionen

  • Division of Field Studies and Engineering, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, Cincinnati, Ohio, USA.
  • Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Coronaviruses and Other Respiratory Viruses Division, National Center for Immunizations and Respiratory Disease, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • American Red Cross, Scientific Affairs, Rockville, Maryland, USA.

ORCID-Profile: Dallas S Shi, Matthew R Groenewold

Förderung

  • Intramural CDC HHS

Zitieren

APA

Shi, D. S., McDonald, E., Shah, M., Groenewold, M. R., Haynes, J. M., Spencer, B. R., Stramer, S. L., Feldstein, L. R., Saydah, S., Jones, J., Chiu, S. K., & Rinsky, J. L. (2024). Prevalence of SARS‐CoV‐2 infection among US blood donors by industry, May–December 2021. American Journal of Industrial Medicine. https://doi.org/10.1002/ajim.23552

Vancouver

Shi DS, McDonald E, Shah M, Groenewold MR, Haynes JM, Spencer BR, et al. Prevalence of SARS‐CoV‐2 infection among US blood donors by industry, May–December 2021. American Journal of Industrial Medicine. 2024. doi:10.1002/ajim.23552

BibTeX
@article{Shi2024,
  author = {Shi, Dallas S and McDonald, Emily and Shah, Melisa and Groenewold, Matthew R and Haynes, James M and Spencer, Bryan R and Stramer, Susan L and Feldstein, Leora R and Saydah, Sharon and Jones, Jefferson and Chiu, Sophia K and Rinsky, Jessica L},
  title = {Prevalence of SARS‐CoV‐2 infection among US blood donors by industry, May–December 2021},
  journal = {American Journal of Industrial Medicine},
  year = {2024},
  doi = {10.1002/ajim.23552}
}
Kostenlos starten →